Amphastar Pharmaceuticals, Inc.AMPHEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products.
What changed in Amphastar Pharmaceuticals, Inc.'s 10-K — 2022 vs 2023
No meaningful paragraph-level changes detected in the compared sections. Either the two filings are nearly identical or the sections did not parse.